Kaskela Law LLC is investigating Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) (“Agios”) on behalf of the company’s long-term investors.
Since December 2024, shares of Agios’ common stock have declined in value from a trading price of over $60.00 per share to a current trading price of under $40.00 per share, a decline of over 33% in value.
The investigation seeks to determine whether Agios and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to investors in connection with recent corporate actions.
Agios shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at 484-229-0750, or by completing the form on this page, to receive additional information about this investigation and their legal rights and options.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
484-229-0750